Secreted miR-210-3p, miR-183-5p and miR-96-5p Reduce Sensitivity to Docetaxel in Prostate Cancer Cells

The authors showed that miR-96-5p, miR-183-5p and miR-210-3p were specifically released by docetaxel resistant prostate cancer clones, and decreased the efficacy of docetaxel in prostate cancer cells when overexpressed.